🇰🇷 TAFASITAMAB in South Korea

TAFASITAMAB (TAFASITAMAB) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

TAFASITAMAB in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is TAFASITAMAB approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for TAFASITAMAB in South Korea?

Marketing authorisation holder not available in our data.